Erschienen in:
12.04.2023 | CE-Research Letter to the Editor
Further data on use of NSAIDs for the home-care therapy of COVID-19
verfasst von:
Francesco Lapi, Ettore Marconi, Ignazio Grattagliano, Claudio Cricelli
Erschienen in:
Internal and Emergency Medicine
|
Ausgabe 5/2023
Einloggen, um Zugang zu erhalten
Excerpt
The initial symptomatology of SARS-CoV-2 infection is generally featured by flu-like symptoms such as fever, pharyngitis, cough, rhinitis, headache, and myalgia for whom home-care pharmacotherapy might be needed [
1]. The use of NSAIDs is recommended by the WHO [
2]
, NICE [
3] as well as other regulatory agencies [
4] and scientific societies [
5] among the mainstays to manage SARS-CoV-2-related early symptoms. …